DNA aneuploidy identifies a subset of Luminal subtype breast carcinoma patients with worse clinical outcome.
Pathol Res Pract
; 246: 154513, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-37167811
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Receptor, ErbB-2
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Pathol Res Pract
Year:
2023
Document type:
Article